Iodine in Pregnancy and Lactation: Why Adequate Intake Matters for Fetal Brain Development

← Back to articles

Severe iodine deficiency in pregnancy is one of the few settled facts in nutrition: it impairs the thyroid hormone supply that the fetal brain depends on and, at its worst, causes the profound, irreversible neurodevelopmental damage historically called cretinism. Salt iodization has nearly eliminated this in regions where it was endemic and is rightly considered a major public-health success. The harder, more contemporary question is what mild-to-moderate iodine deficiency does to the children of mothers who have no clinical symptoms and live in countries considered iodine-sufficient. The honest answer is that the evidence is suggestive but mixed, and this article tries to represent it as it actually stands rather than as either alarming or reassuring.

Why pregnancy raises the iodine requirement

Iodine is a building block of thyroxine, and early in gestation the fetus has no thyroid of its own, so it depends entirely on maternal thyroid hormone until the fetal thyroid becomes functional around mid-pregnancy. To meet the combined demand, maternal thyroid hormone production and renal iodine losses both rise, which is why the World Health Organization sets a higher adequacy target in pregnancy — a median urinary iodine concentration of 150–249 µg/L — than in the general population [1]. A consistent finding across the UK, parts of Europe, and Australia is that a substantial share of pregnant women fall below this threshold despite living in nominally iodine-sufficient countries [2].

What the evidence on mild deficiency and child IQ actually shows

The signal that drew attention came from the UK ALSPAC birth cohort. Among 1,040 mother-child pairs, women whose first-trimester urinary iodine-to-creatinine ratio was below 150 µg/g were more likely to have children in the lowest quartile for verbal IQ at age 8 (adjusted odds ratio 1.58) and for reading scores, after adjusting for 21 confounders [3]. That is an association, expressed as a relative risk rather than a fixed number of IQ points, and the cohort was only mildly-to-moderately deficient overall.

The strongest test of whether this generalises is a 2019 meta-analysis that pooled individual data from three large European cohorts (about 6,180 pairs). It found only a weak, curvilinear relationship: a urinary iodine/creatinine ratio below 150 µg/g was not significantly associated with lower non-verbal or verbal IQ, and any association with verbal IQ was confined to exposure before about 14 weeks of gestation [4]. In other words, the single-cohort finding did not replicate cleanly when more data were combined, though the timing analysis suggests the first trimester is the vulnerable window if there is an effect. The fairest summary is that mild deficiency is biologically plausible as a risk to neurodevelopment, the population-level concern is real, but the magnitude of any individual IQ effect is uncertain and probably small.

Why deficiency persists in "iodine-sufficient" countries

Several trends push intake down. Iodized salt is a shrinking share of total salt because most dietary sodium now comes from processed foods, which generally use non-iodized salt; dairy — a major non-salt iodine source in Western diets — has fallen in some groups, particularly younger women and those using plant-based milks; and the sea salts and specialty salts that have replaced iodized table salt in many kitchens contain little iodine despite their "natural minerals" marketing. Reviews of UK iodine status attribute the re-emergence of mild deficiency in women of childbearing age to exactly this combination [2].

What the supplementation trials found

If mild deficiency lowers child IQ, supplementation should raise it — but the trial evidence has not demonstrated that, partly because the trials have been small and started too late. The clearest example is an Australian randomized, placebo-controlled trial of 150 µg/day iodine in pregnancy that was halted early after its funding was withdrawn; with only 59 women enrolled it found no difference in 18-month neurodevelopmental scores between iodine and placebo, and was far too underpowered to settle the question [5]. Reviewers across the field consistently conclude the same thing: adequately powered trials beginning before or very early in pregnancy are still needed, and existing trials neither prove nor refute a benefit for offspring cognition [1][2]. Supplementation does reliably improve maternal iodine status and thyroid markers.

What the guidelines recommend, and why

Given uncertain individual benefit but a wide safety margin, professional bodies err toward supplementation. The 2017 American Thyroid Association guidelines for thyroid disease in pregnancy recommend that women who are planning pregnancy, pregnant, or breastfeeding in North America take a daily supplement containing about 150 µg iodine, ideally starting before conception [6]. The Recommended Dietary Allowance rises from 150 µg/day in non-pregnant adults to 220 µg/day in pregnancy and 290 µg/day during lactation, the last reflecting the iodine secreted into breast milk for the infant [6]. The supplement is meant to top up a reasonable diet, not to hit those totals on its own.

Practical guidance

Women planning pregnancy, pregnant, or breastfeeding should check whether their prenatal vitamin actually contains iodine — many do not — and choose one supplying around 150 µg if it does not. Use iodized table salt at home rather than sea salt or specialty salts. Crucially, more is not better: iodine has a U-shaped risk curve, and excess can disturb thyroid function. High-dose kelp and seaweed supplements are a particular hazard because their iodine content is highly variable and often very high; a documented case describes a woman with no prior thyroid disease who developed iodine-induced thyrotoxicosis followed by hypothyroidism after a kelp-containing diet product [7]. Women with known thyroid disease (Hashimoto's, Graves', or treated hypothyroidism) should coordinate iodine intake with the clinician managing their thyroid, since both too little and too much can matter, and any supplement decision in pregnancy is best confirmed with a prenatal-care provider.

Sources

1. Trofimiuk-Müldner M, Hubalewska-Dydejczyk A. "Iodine Deficiency and Iodine Prophylaxis in Pregnancy." Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, 2017;10(2):85-95. PMID 28294052.
2. Bath SC, Rayman MP. "A review of the iodine status of UK pregnant women and its implications for the offspring." Environmental Geochemistry and Health, 2015;37(4):619-29. PMID 25663363.
3. Bath SC, Steer CD, Golding J, Emmett P, Rayman MP. "Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC)." Lancet, 2013;382(9889):331-7. PMID 23706508.
4. Levie D, Korevaar TIM, Bath SC, et al. "Association of Maternal Iodine Status With Child IQ: A Meta-Analysis of Individual Participant Data." Journal of Clinical Endocrinology & Metabolism, 2019;104(12):5957-5967. PMID 30920622.
5. Zhou SJ, Skeaff SA, Ryan P, et al. "The effect of iodine supplementation in pregnancy on early childhood neurodevelopment and clinical outcomes: results of an aborted randomised placebo-controlled trial." Trials, 2015;16:563. PMID 26654905.
6. Alexander EK, Pearce EN, Brent GA, et al. "2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum." Thyroid, 2017;27(3):315-389. PMID 28056690.
7. Di Matola T, Zeppa P, Gasperi M, Vitale M. "Thyroid dysfunction following a kelp-containing marketed diet." BMJ Case Reports, 2014;2014:bcr2014206330. PMID 25355748.